Skip to content
The Policy VaultThe Policy Vault

sorafenib genericCigna

Gastrointestinal Stromal Tumor

Initial criteria

  • Patient age ≥ 18 years
  • Patient has previously tried ALL of the following: imatinib, sunitinib, Stivarga (regorafenib tablets), and Qinlock (ripretinib tablets)

Approval duration

1 year